Clinical studies recruiting near Bordeaux

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Generation of an Artificial Intelligence Algorithm Based on the Analysis of Melanoma Peri-scar Dermatoheliosis, as a Pre
Phase N/A · Bordeaux University Hospital · Nantes University Hospital · NCT05856565 A Platform Trial Evaluating New Drugs or Combination in R/R Peripheral T-cell Lymphomas
Phase 1/Phase 2 · The Lymphoma Academic Research Organisation · NCT07018752 A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Phase 3 · CHU de Bordeaux Hop St ANDRE · Eli Lilly and Company · NCT07218380 Glucocorticoids Versus Placebo for the Treatment of Acute Exacerbation of Idiopathic Pulmonary Fibrosis
Phase 3 · CHU BOrdeaux · Fondation Hôpital Saint-Joseph · NCT05674994 This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W
Phase 3 · Institut Bergonié - Centre Régional de Lutte Contre Le Cance · Pfizer · NCT07028853 Tucatinib and Trastuzumab in HER3-mutant and HER2-not Amplified Metastatic Breast Cancer
Phase 2 · Polyclinique Bordeaux Nord Aquitaine · Institut Curie · NCT07193394 Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia
Phase 3 · CHU de Bordeaux · Princess Maxima Center for Pediatric Oncology · NCT05327894 Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease
Phase 2/Phase 3 · CHU de Bordeaux Hop St ANDRE · Bristol-Myers Squibb · NCT07106762 Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Phase 3 · Clinique Tivoli Ducos ( Site 1322) · Merck Sharp & Dohme LLC · NCT06393374 A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)
Phase 2/Phase 3 · Bordeaux University Hospital - Pellegrin ( Site 3605) · Merck Sharp & Dohme LLC · NCT07266831 This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in
Phase 3 · Pfizer · NCT06758401 Efficacy and Safety of MB-CART2019.1 vs. SoC in Lymphoma Patients
Phase 2 · Miltenyi Biomedicine GmbH · NCT04844866 GPS Project Evaluation of the Impact of the Reorganization of Work Into a Family Medicine Group on Pharmacotherapy and S
NA · CHU de Quebec-Universite Laval · NCT04889794 Mechanically or Kinematically Aligned Total Knee Prosthesis
NA · Clinique du Sport, Bordeaux Mérignac · NCT06158646 A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
Phase 1 · Hôpital Saint André - CHU Bordeaux · Seagen, a wholly owned subsidiary of Pfizer · NCT05208762 Selective Internal Radiation Therapy and Capecitabine (Chemotherapy) Treatment for Liver Cancer
Phase 2 · Center Eugene Marquis · NCT05265208 Study of Metabolic, Transcriptomic and Proteomic Characteristics in Relapsed Glioblastoma
Phase N/A · CHU de Bordeaux - Hôpital Saint-André, Service d'Oncologie M · University Hospital, Bordeaux · NCT06430424 PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different Types of Kidney Disease
Phase 2 · HOP Pellegrin · Boehringer Ingelheim · NCT07355296 Study to Assess Safety, Efficacy, and Cellular Kinetics of YTB323 in Generalized Myasthenia Gravis
Phase 1/Phase 2 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT06704269 French Colorectal ESD Cohort in Experts Centers
Phase N/A · CHU de Bordeaux · University Hospital, Limoges · NCT04592003 Metabolic Fluid Responsiveness in Children
Phase N/A · University Hospital, Bordeaux · NCT07255469 A Study of Zasocitinib in Adults With Nonsegmental Vitiligo
Phase 2 · Bordeaux University Hospital · Takeda · NCT07108283 A Study to Assess the Effect of Surovatamig in Adult Participants With Antibody-mediated Kidney Disease
Phase 2 · Research Site · AstraZeneca · NCT07571746 A 52-week Study of Rilzabrutinib Efficacy and Safety Compared to Placebo in Adults Diagnosed With IgG4-related Disease
Phase 3 · Sanofi · NCT07190196 Non-Invasive Ventilation Versus High-flow Nasal Oxygen in Intensive Care Units
NA · Bordeaux University Hospital · Poitiers University Hospital · NCT05686850 A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carbop
Phase 3 · Hoffmann-La Roche · NCT06793215 A Study to Evaluate the Long-term Safety and Tolerability of KarXT and KarX-EC for the Treatment of Schizophrenia and Au
Phase 3 · Local Institution - 0118 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company · NCT07424404 A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants Wit
Phase 1/Phase 2 · Bristol-Myers Squibb · NCT07291076 Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
Phase 1/Phase 2 · Institute Bergonie · CellCentric Ltd. · NCT04068597 Role of High-Throughput Whole Genome Sequencing for the Diagnosis and Care of Atypical Diabetes
NA · University Hospital Haut Lévêque · Institut National de la Santé Et de la Recherche Médicale, F · NCT06570278

Look up another city

Look up another condition